The latest report by IMARC Group, titled “Gene Synthesis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. offers a comprehensive analysis of the industry, which comprises insights on the global gene synthesis market trends. The global market size reached US$ 1.74 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.82 Billion by 2028, exhibiting a growth rate (CAGR) of 17.10% during 2023-2028.
Gene synthesis is the process of artificially creating specific DNA sequences in the laboratory. It enables scientists to design and construct custom-made genes with desired sequences, including modifications, optimizations, or novel genetic material. This technology has diverse applications in molecular biology, biotechnology, and genetic engineering, allowing to produce genes used in recombinant protein expression, gene function studies, synthetic biology applications, and the development of gene therapies. At present, gene synthesis is gaining immense traction across the globe as it plays a pivotal role in advancing genetic research and biotechnological innovations by providing precise control over DNA sequences for various scientific and medical purposes.
Request Your Sample Report Now: https://www.imarcgroup.com/gene-synthesis-market/requestsample
Gene Synthesis Market Trends and Drivers:
The global gene synthesis market is primarily driven by numerous advancements in molecular biology and biotechnology that expand the applications of gene synthesis, including gene editing, synthetic biology, and the development of biopharmaceuticals. Moreover, the increasing demand for customized DNA sequences for research, therapeutics, and diagnostics is propelling market growth. Apart from this, the rising need for automation and cost reduction in gene synthesis processes that improve the accessibility and affordability of these services has catalyzed market growth. Additionally, the heightening interest in precision medicine and personalized therapies has escalated the demand for gene synthesis in the healthcare sector, thereby fostering market growth. Furthermore, escalating importance of gene synthesis in the development of vaccines and diagnostics amid the COVID-19 pandemic is contributing to market growth
Report Segmentation:
The report has segmented the market into the following categories:
Method Insights:
- Solid-Phase Synthesis
- Chip-Based Synthesis
- PCR-Based Enzyme Synthesis
Services Insights:
- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
Application Insights:
- Gene and Cell Therapy Development
- Vaccine Development
- Disease Diagnosis
- Others
End Use Insights:
- Biotechnology and Pharmaceutical Companies
- Academic and Government Research Institutes
- Contract Research Organizations
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- ATUM
- Boster Biological Technology
- Eurofins Genomics
- Genewiz Inc. (Azenta Life Sciences)
- Genscript Biotech Corp.
- Integrated DNA Technologies Inc.
- Merck KGaA
- OriGene Technologies Inc.
- ProMab Biotechnologies Inc.
- ProteoGenix Inc
- Thermo Fisher Scientific Inc.
- Twist Bioscience
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
About Author
